We used RNA-seq to screen gene expression levels in local advanced lung adenocarcinoma patients who received EGFR-TKI (gefitinib or ecotinib) therapy (Additional file 1; Table S2). The gene discussed is EGFR; the disease is lung adenocarcinoma.